Cover Image

Normalization of tumor vessels by Tie2 activation and Ang2 inhibition enhances drug delivery and produces a favorable tumor microenvironment

A destabilized tumor vasculature leads to limited drug delivery, hypoxia, detrimental tumor microenvironment, and even metastasis. We performed a side-by-side comparison of ABTAA (Ang2-Binding and Tie2-Activating Antibody) and ABA (Ang2-Blocking Antibody) in mice with orthotopically implanted glioma...

Full description

Saved in:
Bibliographic Details
Main Authors: Park, Jin-Sung (Author) , Augustin, Hellmut (Author)
Format: Article (Journal)
Language:English
Published: December 12, 2016
In: Cancer cell
Year: 2016, Volume: 30, Issue: 6, Pages: 953-967
ISSN:1878-3686
DOI:10.1016/j.ccell.2016.10.018
Online Access:Verlag, Volltext: https://doi.org/10.1016/j.ccell.2016.10.018
Verlag: http://www.sciencedirect.com/science/article/pii/S1535610816305050
Get full text
Author Notes:Jin-Sung Park, Il-Kug Kim, Sangyeul Han, Intae Park, Chan Kim, Jeomil Bae, Seung Ja Oh, Seungjoo Lee, Jeong Hoon Kim, Dong-Cheol Woo, Yulong He, Hellmut G. Augustin, Injune Kim, Doheon Lee, and Gou Young Koh
Description
Summary:A destabilized tumor vasculature leads to limited drug delivery, hypoxia, detrimental tumor microenvironment, and even metastasis. We performed a side-by-side comparison of ABTAA (Ang2-Binding and Tie2-Activating Antibody) and ABA (Ang2-Blocking Antibody) in mice with orthotopically implanted glioma, with subcutaneously implanted Lewis lung carcinoma, and with spontaneous mammary cancer. We found that Tie2 activation induced tumor vascular normalization, leading to enhanced blood perfusion and chemotherapeutic drug delivery, markedly lessened lactate acidosis, and reduced tumor growth and metastasis. Moreover, ABTAA favorably altered the immune cell profile within tumors. Together, our findings establish that simultaneous Tie2 activation and Ang2 inhibition form a powerful therapeutic strategy to elicit a favorable tumor microenvironment and enhanced delivery of a chemotherapeutic agent into tumors.
Item Description:Gesehen am 31.10.2019
Physical Description:Online Resource
ISSN:1878-3686
DOI:10.1016/j.ccell.2016.10.018

Similar Items